Showing results (141-150 of 147) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 147 results.
Cancer Letters|February 26, 2018
Haploidentical IL-15/41BBL activated and expanded natural killer cell infusion therapy after salvage chemotherapy in children with relapsed and refractory leukemiaM Vela, D Corral, P Carrasco, et al.
Cancer|November 22, 2022
Potentially inappropriate medications in geriatric blood or marrow transplantation (BMT) survivors: A BMT Survivor Study reportSebastian Sanchez-Luege, Wendy Landier, Chen Dai, et al.
Cancer|December 9, 2022
Severe, life-threatening, and fatal chronic health conditions after allogeneic blood or marrow transplantation in childhoodAnna Sällfors Holmqvist, Yanjun Chen, Lindsey Hageman, et al.
Frontiers in Cell and Developmental Biology|March 15, 2021
SARS-CoV-2-Specific Memory T Lymphocytes From COVID-19 Convalescent Donors: Identification, Biobanking, and Large-Scale Production for Adoptive Cell TherapyC Ferreras, B Pascual-Miguel, C Mestre-Durán, et al.
British Journal of Haematology|September 21, 2001
Disparity for the minor histocompatibility antigen HA-1 is associated with an increased risk of acute graft-versus-host disease (GvHD) but it does not affect chronic GvHD incidence, disease-free survival or overall survival after allogeneic human leucocyte antigen-identical sibling donor transplantationD Gallardo, J I Aróstegui, A Balas, et al.
Eclinicalmedicine|August 18, 2021
Phase I dose-escalation single centre clinical trial to evaluate the safety of infusion of memory T cells as adoptive therapy in COVID-19 (RELEASE)A Pérez-Martínez, M Mora-Rillo, C Ferreras, et al.
Transplantation Proceedings|December 10, 2016
Report From the First and Second Spanish Killer Immunoglobulin-Like Receptor Genotyping Workshops: External Quality Control for Natural Killer Alloreactive Donor Selection in Haploidentical Stem Cell TransplantationD Planelles, C Vilches, F González-Escribano, et al.
Pageof 15